Madrigal Pharmaceuticals Inc. (MDGL) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear

Madrigal Pharmaceuticals ...

NASDAQ: MDGL · Real-Time Price · USD
424.23
1.24 (0.29%)
At close: Sep 26, 2025, 3:59 PM
423.48
-0.18%
After-hours: Sep 26, 2025, 07:57 PM EDT

Madrigal Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
100.02M 99.92M 331.55M 36.27M
Short-Term Investments
826.23M 534.22M 27.23M 234.08M
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
n/a n/a n/a n/a
Receivables
53.82M n/a n/a n/a
Inventory
34.07M n/a n/a n/a
Other Current Assets
18.79M 3.15M 2.6M 1.34M
Total Current Assets
1.03B 637.28M 361.37M 271.68M
Property-Plant & Equipment
4.59M 3.27M 1.2M 1.65M
Goodwill & Intangibles
4.73M n/a n/a n/a
Total Long-Term Assets
9.32M 3.27M 1.2M 1.65M
Total Assets
1.04B 640.55M 362.57M 273.33M
Account Payables
43.6M 28.04M 23.83M 21.38M
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
983K n/a n/a n/a
Other Current Liabilities
89.74M 72.95M n/a 6.77M
Total Current Liabilities
169.28M 118.55M 115.89M 76.84M
Long-Term Debt
117.57M 115.48M 49.29M n/a
Other Long-Term Liabilities
n/a n/a n/a n/a
Total Long-Term Liabilities
118.59M 116.67M 49.29M 387K
Total Liabilities
287.86M 235.21M 165.18M 77.22M
Total Debt
119.57M 117.19M 49.89M 797K
Book Value
754.38M 405.33M 197.39M 196.11M
Book Value Per Share
35.46 21.69 11.52 11.86
Common Stock
2K 2K 2K 2K
Retained Earnings
-1.8B -1.34B -962.66M -667.31M
Comprehensive Income
468K 468K -32K -80K
Shareholders Equity
754.38M 405.33M 197.39M 196.11M
Total Investments
826.23M 534.22M 27.23M 234.08M